1. Home
  2. THRD vs NRGV Comparison

THRD vs NRGV Comparison

Compare THRD & NRGV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • THRD
  • NRGV
  • Stock Information
  • Founded
  • THRD 2019
  • NRGV 2017
  • Country
  • THRD United States
  • NRGV United States
  • Employees
  • THRD N/A
  • NRGV N/A
  • Industry
  • THRD Biotechnology: Pharmaceutical Preparations
  • NRGV Industrial Machinery/Components
  • Sector
  • THRD Health Care
  • NRGV Miscellaneous
  • Exchange
  • THRD Nasdaq
  • NRGV Nasdaq
  • Market Cap
  • THRD 232.4M
  • NRGV 190.1M
  • IPO Year
  • THRD 2022
  • NRGV N/A
  • Fundamental
  • Price
  • THRD $5.25
  • NRGV $0.92
  • Analyst Decision
  • THRD Hold
  • NRGV Buy
  • Analyst Count
  • THRD 3
  • NRGV 3
  • Target Price
  • THRD $5.00
  • NRGV $1.58
  • AVG Volume (30 Days)
  • THRD 296.2K
  • NRGV 1.3M
  • Earning Date
  • THRD 05-08-2025
  • NRGV 05-12-2025
  • Dividend Yield
  • THRD N/A
  • NRGV N/A
  • EPS Growth
  • THRD N/A
  • NRGV N/A
  • EPS
  • THRD N/A
  • NRGV N/A
  • Revenue
  • THRD N/A
  • NRGV $46,974,000.00
  • Revenue This Year
  • THRD N/A
  • NRGV $392.18
  • Revenue Next Year
  • THRD N/A
  • NRGV $48.23
  • P/E Ratio
  • THRD N/A
  • NRGV N/A
  • Revenue Growth
  • THRD N/A
  • NRGV N/A
  • 52 Week Low
  • THRD $3.18
  • NRGV $0.60
  • 52 Week High
  • THRD $16.02
  • NRGV $2.70
  • Technical
  • Relative Strength Index (RSI)
  • THRD 75.64
  • NRGV 53.38
  • Support Level
  • THRD $5.16
  • NRGV $0.80
  • Resistance Level
  • THRD $5.22
  • NRGV $1.00
  • Average True Range (ATR)
  • THRD 0.04
  • NRGV 0.10
  • MACD
  • THRD -0.03
  • NRGV -0.01
  • Stochastic Oscillator
  • THRD 100.00
  • NRGV 40.15

About THRD Third Harmonic Bio Inc.

Third Harmonic Bio Inc is a biopharmaceutical company focused on the development of the next wave of medicine for the treatment of inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases. The company's product candidate, THB001, is a selective, oral small-molecule inhibitor of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. Its other product candidate THB335, is a potent, selective, oral small molecule KIT inhibitor, for the treatment of multiple mast cell-driven inflammatory diseases of the skin, airway, and gastrointestinal tract.

About NRGV Energy Vault Holdings Inc.

Energy Vault Holdings Inc is a grid-scale energy storage company that is driving a faster transition to renewable power by solving the intermittence issues that are inherent to the prevalent sources of renewable energy, solar and wind. Geographical presence in United States, China and Other. Majority of its revenue comes from U.S.

Share on Social Networks: